Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,593 INR | +0.84% | -0.51% | +27.25% |
Strengths
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's earnings growth outlook lacks momentum and is a weakness.
- With an expected P/E ratio at 28.19 and 24.37 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Agricultural Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+27.25% | 5.57B | B- | ||
-16.06% | 14.72B | D+ | ||
-11.77% | 12.79B | B+ | ||
+5.64% | 12.22B | C | ||
-23.93% | 8.85B | B+ | ||
-.--% | 7.62B | - | C- | |
-18.36% | 7.27B | A- | ||
-21.55% | 5.2B | - | ||
+38.63% | 2.49B | C | ||
+3.51% | 2.07B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- COROMANDEL Stock
- Ratings Coromandel International Limited